Recent advances in neoadjuvant therapy for breast cancer

Neoadjuvant trials for early breast cancer have accelerated the identification of novel active agents, enabling streamlined conduct of registration trials with fewer subjects. Measurement of neoadjuvant drug effects has also enabled the identification of patients with high risk of distant recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Potter, David A, Herrera-Ponzanelli, César A, Hinojosa, Diego, Castillo, Rafael, Hernandez-Cruz, Irwin, Arrieta, Victor A, Franklin, Michael J, Yee, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty Opinions Ltd 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894264/
https://www.ncbi.nlm.nih.gov/pubmed/33659921
http://dx.doi.org/10.12703/r/10-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894264/
https://www.ncbi.nlm.nih.gov/pubmed/33659921
http://dx.doi.org/10.12703/r/10-2

Ejemplares similares